Open access
Aug 2026
A plasma‐based protein signature combining NPTXR, ACHE, and p‐tau217 predicts progression to symptomatic Alzheimer's disease
Whether these proteins, alone or combined with plasma phosphorylated tau 217 (p‐tau217), predict progression from cognitively unimpaired to symptomatic AD is evaluated.
Menghan Liu, Katherine Gong, Yike Chen et al.
· Alzheimer's & Dementia · 0 citations